单独和合用硒化壳聚糖与阿霉素对K562细胞作用的研究

应用MTT法和AO／EB荧光染色法观察单独和合用硒化壳聚糖与阿霉素对K562细胞株的影响,结果发现硒化壳聚糖和阿霉素均可有效地抑制K562细胞生长。且两药联合使用效果更佳。硒化壳聚糖可诱导细胞凋亡。两药合用诱导细胞凋亡效果更好。     

硒化壳聚糖对K 562和K 562/ADM作用的比较研究

应用MTT法和细胞集落形成率法观察了硒化壳聚糖对K562和K562／ADM肿瘤细胞株生长的影响，结果发现硒化壳聚糖可有效地抑制两种K562细胞生长，呈量效关系。同等剂量的硒化壳聚糖对K562细胞的作用强度高于对K562／ADM细胞。硒化壳聚糖对耐药的细胞株可产生抑制作用，若与化疗药合用则可减慢甚至部分逆转临床上K562细胞耐药性的发生。     

硒化壳聚糖对NB4细胞作用的实验研究

应用MTT法、AO/EB荧光染色法和NBT还原法观察硒化壳聚糖对NB4肿瘤细胞株生长的影响。结果发现,硒化壳聚糖可有效地抑制NB4细胞生长,并呈量效、时效关系。经100 mg/L及以上剂量硒化壳聚糖作用后的细胞可明显出现核固缩、碎裂等凋亡形态改变。而经100 mg/L以下剂量硒化壳聚糖作用后,细胞可出现诱导分化成熟的表现。     

硒化壳聚糖诱导NB4细胞凋亡及周期阻断作用

为研究硒化壳聚糖对NB4细胞的凋亡及周期阻断作用,用流式细胞法观察了药物对细胞的诱导凋亡及周期阻断作用。结果表明,硒化壳聚糖作用NB4细胞24 h,可剂量依赖性地诱导细胞凋亡并使G0—G1期细胞增多。提示硒化壳聚糖可诱导细胞凋亡,并对NB4细胞周期有特异性阻断作用。     

硒代二半胱氨酸对白血病细胞系的诱导分化研究

硒抑制体外白血病细胞的生长和增殖．并能诱导部分白血病细胞分化成熟。但其药理作用因硒制剂的不同而异．硒代二半胱氨酸抑制V937和K562血病细胞的生长和增殖，半数抑制浓度为3．0μmol／L，经30μmol／L硒代二半胱氨酸作用3天后，U937胞吞噬率以5％上升至14％，K562细胞内血红蛋白含量由0．20增至0．40μg／10^6细胞，说明硒代二半胱氨酸能诱导部分白血病细胞分化成熟。     

硒化聚甘露糖醛酸的合成及抗阿尔茨海默症细胞氧化与凋亡

以聚甘露糖醛酸为原料, 采用先磺化、 再硒化的方法合成了硒化聚甘露糖醛酸, 产率为54%, 产物硒含量为437.25 μg/g. 在2.5 μmol/L硒浓度下, 硒化聚甘露糖醛酸促细胞生长能力达到最适范围, 能保护细胞免受过氧化氢损伤, 显著提高阿尔茨海默症(AD)模型细胞N2a-APP695-sw中的超氧化物歧化酶和谷胱甘肽过氧化物酶的活性, 降低细胞内活性氧自由基, 增加线粒体膜电位, 抑制细胞色素C的释放, 在促进Bcl-2表达的同时抑制Bax的表达, 从而具有抑制AD细胞凋亡的功能. 硒化聚甘露糖醛酸也能抑制AD病理相关蛋白BACE1和APP的表达. 结果表明, 硒化聚甘露糖醛酸在抗AD方面具有潜在的应用前景.     

硒化壳聚糖抑制人早幼粒白血病细胞增殖的研究

为探讨硒化壳聚糖对体外培养人早幼粒白血病细胞增殖的抑制作用,用SRB法和集落形成法检测了药物对细胞增殖的抑制作用,流式法检测了细胞周期阻断作用。结果表明,25、50、100mg／L硒化壳聚糖作用HL60细胞48h对细胞有增殖抑制作用（P〈0．01）;50、100mg／L硒化壳聚糖作用细胞48h后,G0／G1期细胞数较对照组增加了14．9％-22．0％（P〈0．05）,S期细胞减少了14．3％～20．1％（P〈0．05）。可见硒化壳聚糖对人早幼粒白血病细胞增殖具有抑制作用。     

N'-叔丁氨基羰基-N-(5-取代苯基-2-呋喃甲酰基)硫脲的合成及对白血病K562细胞增殖的影响

将活性基团5-取代苯基呋喃环和叔丁氨基引入酰基硫脲的分子骨架中,设计合成了8个未见文献报道的N'-叔丁氨基羰基-N-(5-取代苯基-2-呋喃甲酰基)硫脲类化合物(5a～5h),结构经元素分析、IR和 1H NMR等测试技术得到确证. 经MTT(溴化3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑)法观察,首次发现目标化合物对白血病K562细胞的增殖有明显的抑制作用. 在药物浓度为100×10-6 g/mL时,大部分目标化合物对白血病K562细胞生长的抑制率超过了70%,化合物5a对白血病K562细胞生长的抑制率达到77.14%. 其中,目标化合物5f和5h对白血病K562细胞有诱导作用,进一步的测试正在进行中.     

18β-甘草次酸A环官能团化衍生物的合成及抗肿瘤活性

采用化学方法对18β-甘草次酸A环进行改造, 合成了一系列新型18β-甘草次酸A环官能团化衍生物. 对人白血病细胞株HL-60、K562、肝癌细胞BEL-7404及乳腺癌细胞MDA-MB-231的体外抗肿瘤活性筛选结果表明, 化合物5对4种肿瘤细胞系的抑制活性均强于18β-甘草次酸; 构效关系分析表明, A环内烯键的形成对抑制肿瘤细胞增殖有重要影响; 同时利用Hoechst33258和AO/EB染色, 在荧光显微镜下观察到了细胞凋亡小体的形成.     

硒与端粒酶

硒是人体必需微量元素,它参与抗氧化酶谷胱甘肽过氧化物酶和多种硒蛋白的组成,在体内发挥消除自由基、抗氧化物等作用。硒的抗衰老与抑制肿瘤细胞生长的作用是通过它对端粒酶的作用而实现的。研究端粒酶的调控及其与细胞凋亡的关系已成为人类种瘤研究的新热点。     

The cellular labeling and pH-sensitive responsive-drug release of celastrol in cancer cells based on Cys-CdTe QDs

As one of the active compounds derived from Traditional Chinese Medicine,Celastrol(CSL)had cytotoxicity for human leukemia cancer cells K562 and its multidrug-resistant cell line K562/A02.Here,we introduced cysteamine-modified CdTe QDs as the labeling and drug carrier into CSL research and found that the self-assembly and conjugation of anticancer molecular CSL with the Cys-CdTe QDs could significantly increase the drug’s cytotoxicity for K562 cells.More important,these CSL-Cys-CdTe nanocomposites could overcome the multidrug resistance of K562/A02 cells and efficiently inhibit the cancer cell proliferation by realizing the pH-sensitive responsive release of CSL to cancer cells.The enhanced cytotoxicity was caused by the increase of the G2/M phase arrest for K562/A02 cells as well as for K562 cells.Cys-CdTe QDs can readily bind on the cell plasma membranes and be internalized into cancer cells to trace and detect human leukemia cancer cells in real time.In addition,these Cys-CdTe QDs can facilitate the inhibition of the multidrug resistance of K562/A02 cells and readily induce apoptosis.As a good photosensitizer for the therapy,labeling,and tracing of cancer cells,the combination of CSL with Cys-CdTe QDs can optimize the use of and a new potential therapy method for CSL and yield new tools to explore the mechanisms of active compounds from Traditional Chinese Medicine.     

Photodynamic treatment (ALA-PDT) suppresses the expression of the oncogenic Bcr-Abl kinase and affects the cytoskeleton organization in K562 cells

K562 is the chronic myelogenous leukemia (CML)-derived cell line that expresses high levels of chimeric oncoprotein Bcr-Abl. The deregulated (permanent) kinase activity of Bcr-Abl leads to continuous proliferation of K562 cells and their resistance to the apoptosis promotion by conventional drugs. The photodynamic treatment (PDT) based on the application of 5-aminolevulinic acid (ALA) and irradiation with blue light (ALA-PDT) resulted in the suppression of K562 cells proliferation. It was followed by a necrosis-like cell death [K. Kuzelová, D. Grebenová, M. Pluskalová, I. Marinov, Z. Hrkal, J. Photochem. Photobiol. B 73 (2004) 67-78]. ALA-PDT led to the perturbation of the Hsp90/p23 multichaperone complex of which the Bcr-Abl is the client protein. Bcr-Abl protein was suppressed whereas the bcr-abl mRNA level was not affected. Further on, we observed several changes in the cytoskeleton organization. We detected ALA-PDT-mediated disruption of filamental actin structure using FITC-Phalloidin staining. In connection with this we uncovered certain cytoskeleton organizing proteins involved in the cell response to the treatment. Among these proteins, Septin2, which plays a role in maintaining actin bundles, was suppressed. Another one, PDZ-LIM domain protein 1 (CLP36) was altered. This protein acts as an adaptor molecule for LIM-kinase which phosphorylates and thus inactivates cofilin. Cofilin was indeed dephosphorylated and could thus be activated and operate as an actin-depolymerizing factor. We propose the scheme of molecular response of K562 cells to ALA-PDT.     

硒代二半胱氨酸对白血病细胞系谷胱甘肽过氧化物酶的影响

观察了硒代二半胱氨酸对白血病细胞系（Ｕ９３７和Ｋ５６２）生长增殖和谷胱甘肽过氧化物酶的影响．结果表明，硒代二半胱氨酸抑制白血病细胞生长和增殖，其抑制作用与药物浓度呈正相关．经３．０μｍｏｌ／Ｌ（ＩＣ５０）硒代二半胱氨酸作用３天后（Ｕ９３７和Ｋ５６２白血病细胞内谷胱甘肽过氧化物酶活性显著提高（Ｐ＜０．０１），在培养第３天和第６天时无显著差别．谷胱甘肽过氧化物酶活性的提高有利于白血病细胞生长的抑制．     

Lethal Effect of Benzene Nitrogen Mustard Glucoside Derivate on K562 Cells

A new synthesized benzene nitrogen mustard was converted into glycosyl donor-trichloroacetimidate that was glycosylated with p-nitrophenol（glycosyl donors） to form β-lactosyl p-nitrobenzene under the protection of acetyl in a stereoselective manner, was prepared and evaluated for its cytotoxicity towards cultured K562 cell line. Methylthiazoy tetrazolium（MTT） assay, transmission electron microscopy（TEM）, flow cytometry（FCM） and immunohistochemistry were utilized to explore the mechanisms of how the compound arrests the growth of HCT-T cells. This new synthesed benzene nitrogen mustard glucoside derivate（BNMGD） presented a lower toxicity to normal cells, but is significantly more toxic to K562 cells compared with nitrogen mustard, meanwhile it can induce the apoptosis of K562 cells. These results indicate that the new synthesized BNMGD can inhibit the growth of K562 cells and induce the apoptosis, and its cytotoxicity towards cultured K562 cell line is much more effective than that of nitrogen mustard.     

MTT法测定稀土离子对BEL-7402及K562细胞的毒性及增殖毒性

用MTT法测定稀土离子在不同浓度、不同培养液中,与BEL 7402和K562细胞作用不同时间,对细胞的毒性和增殖毒性。结果表明,在含10%小牛血清培养液中,仅个别稀土离子在较高浓度时对BEL 7402细胞增殖有较弱的抑制作用;对于K562细胞,稀土离子在低浓度时对细胞增殖即表现出较强的抑制作用(P<0.05)。当培养液不含小牛血清时,较低浓度的稀土离子即可抑制BEL 7402细胞的增殖(P<0 05)。     

Tanshinone IIA, an ingredient of Salvia miltiorrhiza BUNGE, induces apoptosis in human leukemia cell lines through the activation of caspase-3

Tanshinone II-A is a derivative of phenanthrene-quinone isolated from Salvia miltiorrhiza BUNGE, a traditional herbal medicine that is known to induce antiinflammatory, anti-oxidative and cytotoxic activity. We have examined cellular effects of Tanshione II-A on HL60 human promyelocytic leukemic cells and K562 human erythroleukemic cells. Tanshione II-A induced a dose- and time-dependent DNA fragmentation into the multiples of 180 bp and specific proteolytic cleavage of poly(ADP-ribose) polymerase in both cell lines. PI-staining and flow cytometry analysis of K562 cells following Tanshione II-A treatment showed an increase of the cells possessing hypodiploid DNA indicative of apoptotic state of cells. Caspase-3 activity was significantly increased during Tanshinone II-A treatment of both HL60 and K562 cells, whereas caspase-1 activity was not changed. These results suggest that Tanshione II-A induced HL60 and K562 cellular apoptosis that may be associated with the selective members of caspase family.     

Blocking ACAT‐1 Activity for Tumor Therapy with Fluorescent Hyperstar Polymer‐Encapsulated Avasimible

Targeting the distinct cholesterol metabolism of tumor cells is proposed as a novel way to treat tumors. Blocking acyl‐CoA cholesterol acyltransferase‐1 (ACAT‐1) by the inhibitor avasimible (Ava), which elevates intracellular free cholesterol levels, is shown to effectively induce apoptosis. However, Ava faces disadvantages of poor water solubility, a short half‐life, and no capability for fluorescence detection, which have greatly limited its application. Herein, a fluorescent hyperstar polymer (FHSP) is developed to encapsulate Ava to improve its ability to inhibit HeLa cells and K562 cells. The results of this study show that the obtained Ava–FHSP micelles possess a high drug loading capacity of 22.7% and bright green fluorescence. Ava and Ava–FHSP are cytotoxic to both HeLa and K562 cells and cause reductions in cell size, nuclear lysis, and chromatin condensation and hindered proliferation of both cell types by causing S phase cell cycle arrest. Further mechanistic analysis indicates that Ava–FHSP reduces the protein and messenger RNA expression of ACAT‐1 and significantly increases intracellular free cholesterol levels, which can increase endoplasmic reticulum stress and finally cause cell apoptosis. All these results suggest that this fluorescent hyperstar polymer represents a potential therapeutic tumor strategy by changing the cholesterol metabolism of tumor cells.